Literature DB >> 21432058

Keynote lecture in the 13th Japanese Society of Immunotoxicology (JSIT 2006) : -Pathophysiological Development and Immunotoxicology: what we have found from research related to silica and silicate such as asbestos-.

Takemi Otsuki1, Yoshie Miura, Megumi Maeda, Hiroaki Hayashi, Shuko Murakami, Maolong Dong, Yasumitsu Nishimura.   

Abstract

Silica and silicates may disturb immune functions such as autoimmunity and tumor immunity, because people who are exposed to the materials sometimes develop autoimmune and malignant diseases, respectively. Although silica-induced disorders of autoimmunity have been explained as adjuvant-type effects of silica, more precise analyses are needed and should reflect the recent progress in immunomolecular findings. A brief summary of our investigations related to the immunological effects of silica/asbestos is presented. Recent advances in immunomolecular studies led to detailed analyses of the immunological effects of asbestos and silica. Both affect immuno-competent cells and these effects may be associated with the pathophysiological development of complications in silicosis and asbestos-exposed patients such as the occurrence of autoimmune disorders and malignant tumors, respectively. In addition, immunological analyses may lead to the development of new clinical tools for the modification of the pathophysiological aspects of diseases such as the regulation of autoimmunity or tumor immunity using cell-mediated therapies, various cytokines, and molecule-targeting therapies. In particular, as the incidence of asbestos-related malignancies is increasing and such malignancies have been a medical and social problem since the summer in 2005 in Japan, efforts should be focused on developing a cure for these diseases to eliminate the nation wide anxiety about these malignancies.

Entities:  

Keywords:  apoptosis; asbestos; immunology Fas; regulatory T cell; silica

Year:  2007        PMID: 21432058      PMCID: PMC2723295          DOI: 10.1007/BF02897984

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  65 in total

1.  Rheumatoid pneumoconiosis. A case of Caplan's syndrome in a chalk-mine worker.

Authors:  J LAMVIK
Journal:  Acta Pathol Microbiol Scand       Date:  1963

2.  Over-expression of the decoy receptor 3 (DcR3) gene in peripheral blood mononuclear cells (PBMC) derived from silicosis patients.

Authors:  T Otsuki; A Tomokuni; H Sakaguchi; T Aikoh; T Matsuki; Y Isozaki; F Hyodoh; H Ueki; M Kusaka; S Kita; A Ueki
Journal:  Clin Exp Immunol       Date:  2000-02       Impact factor: 4.330

3.  Soluble Fas mRNA is dominantly expressed in cases with silicosis.

Authors:  T Otsuki; H Sakaguchi; A Tomokuni; T Aikoh; T Matsuki; Y Kawakami; M Kusaka; H Ueki; S Kita; A Ueki
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

4.  Detection of alternatively spliced variant messages of Fas gene and mutational screening of Fas and Fas ligand coding regions in peripheral blood mononuclear cells derived from silicosis patients.

Authors:  T Otsuki; H Sakaguchi; A Tomokuni; T Aikoh; T Matsuki; Y Isozaki; F Hyodoh; Y Kawakami; M Kusaka; S Kita; A Ueki
Journal:  Immunol Lett       Date:  2000-05-01       Impact factor: 3.685

5.  Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer.

Authors:  R M Pitti; S A Marsters; D A Lawrence; M Roy; F C Kischkel; P Dowd; A Huang; C J Donahue; S W Sherwood; D T Baldwin; P J Godowski; W I Wood; A L Gurney; K J Hillan; R L Cohen; A D Goddard; D Botstein; A Ashkenazi
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

Review 6.  Breast implants: facts, controversy, and speculations for future research.

Authors:  M E Jenkins; H I Friedman; A F von Recum
Journal:  J Invest Surg       Date:  1996 Jan-Feb       Impact factor: 2.533

7.  Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule.

Authors:  J Cheng; T Zhou; C Liu; J P Shapiro; M J Brauer; M C Kiefer; P J Barr; J D Mountz
Journal:  Science       Date:  1994-03-25       Impact factor: 47.728

8.  Fas ligand in human serum.

Authors:  M Tanaka; T Suda; K Haze; N Nakamura; K Sato; F Kimura; K Motoyoshi; M Mizuki; S Tagawa; S Ohga; K Hatake; A H Drummond; S Nagata
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

9.  Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis.

Authors:  A Bettinardi; D Brugnoni; E Quiròs-Roldan; A Malagoli; S La Grutta; A Correra; L D Notarangelo
Journal:  Blood       Date:  1997-02-01       Impact factor: 22.113

10.  Early mesothelial cell proliferation after asbestos exposure: in vivo and in vitro studies.

Authors:  I Y Adamson
Journal:  Environ Health Perspect       Date:  1997-09       Impact factor: 9.031

View more
  1 in total

1.  Cytokine alteration and speculated immunological pathophysiology in silicosis and asbestos-related diseases.

Authors:  Shuko Murakami; Yasumitsu Nishimura; Megumi Maeda; Naoko Kumagai; Hiroaki Hayashi; Ying Chen; Masayasu Kusaka; Takumi Kishimoto; Takemi Otsuki
Journal:  Environ Health Prev Med       Date:  2009-03-18       Impact factor: 3.674

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.